stage iv prostate cancer
Showing 1 - 25 of 94
Hormone-Resistant Prostate Cancer, Metastatic Prostate Carcinoma, Prostate Carcinoma Metastatic in the Bone Trial in United
Recruiting
- Hormone-Resistant Prostate Cancer
- +3 more
-
Ann Arbor, Michigan
- +3 more
Feb 2, 2023
Hormone-Resistant Prostate Cancer, Metastatic Malignant Tumor in the Bone, Metastatic Malignant Tumor in the Soft Tissues Trial
Active, not recruiting
- Hormone-Resistant Prostate Cancer
- +6 more
- Pembrolizumab
- pTVG-HP Plasmid DNA Vaccine
-
Madison, WisconsinUniversity of Wisconsin Carbone Cancer Center
Nov 8, 2022
Recurrent Prostate Cancer, Stage IV Prostate Cancer Trial in Columbus (behavioral, other, procedure)
Active, not recruiting
- Recurrent Prostate Cancer
- Stage IV Prostate Cancer
- behavioral dietary intervention
- +5 more
-
Columbus, OhioArthur G. James Cancer Hospital and Solove Research Institute at
Jun 3, 2022
Prostate Cancer, Stage IV Prostate Cancer Trial in Tampa (Luteinizing Hormone Releasing Hormone, New Hormonal Agent, Docetaxel)
Recruiting
- Prostate Cancer
- Stage IV Prostate Cancer
- Luteinizing Hormone Releasing Hormone
- +3 more
-
Tampa, FloridaMoffitt Cancer Center
Jun 1, 2022
Recurrent Prostate Cancer, Stage IV Prostate Cancer Trial in Columbus (Arm I Soy Bread, Arm II Soy-Almond Bread)
Active, not recruiting
- Recurrent Prostate Cancer
- Stage IV Prostate Cancer
- Arm I Soy Bread
- Arm II Soy-Almond Bread
-
Columbus, OhioThe Ohio State University Medical Center
Apr 29, 2022
Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma Trial in San Francisco
Active, not recruiting
- Castration Levels of Testosterone
- +6 more
- Lutetium Lu 177-PSMA-617
- Pembrolizumab
-
San Francisco, CaliforniaUniversity of California, San Francisco
Apr 11, 2022
Adenocarcinoma of the Prostate, Stage IIB Prostate Cancer, Stage III Prostate Cancer Trial in Duarte (biological, procedure,
Active, not recruiting
- Adenocarcinoma of the Prostate
- +3 more
- anti-PSMA monoclonal antibody MDX1201-A488
- +5 more
-
Duarte, CaliforniaCity of Hope Medical Center
Mar 17, 2022
Metastatic Prostate Carcinoma, Recurrent Prostate Carcinoma, Stage IV Prostate Cancer Trial in Sacramento (Abiraterone Acetate,
Active, not recruiting
- Metastatic Prostate Carcinoma
- +2 more
- Abiraterone Acetate
- +2 more
-
Sacramento, CaliforniaUniversity of California Davis Comprehensive Cancer Center
Feb 23, 2022
Metastatic Prostate Carcinoma, Recurrent Prostate Carcinoma, Stage IV Prostate Cancer Trial in Sacramento (Enzalutamide,
Active, not recruiting
- Metastatic Prostate Carcinoma
- +2 more
-
Sacramento, CaliforniaUniversity of California Davis Comprehensive Cancer Center
Feb 23, 2022
Stage IV Prostate Cancer Trial in Baltimore (procedure, drug, other, biological)
Completed
- Stage IV Prostate Cancer
- Cryosurgery
- +3 more
-
Baltimore, MarylandJohns Hopkins University/Sidney Kimmel Cancer Center
Nov 11, 2021
Stage II Breast Cancer, Stage III Breast Cancer, Stage IV Breast Cancer Trial in United States (Behavioral Intervention)
Recruiting
- Stage II Breast Cancer
- +22 more
- Behavioral Intervention
-
Bay City, Michigan
- +7 more
Sep 29, 2021
Recurrent Malignant Solid Tumor, Stage IV Breast Cancer, Stage IV Prostate Cancer Trial in Washington (Canady Helios Cold Plasma
Active, not recruiting
- Recurrent Malignant Solid Neoplasm
- +15 more
- Canady Helios Cold Plasma Scalpel
-
Washington, District of ColumbiaCanady Surgical Group PC
Jul 16, 2021
Hormone-Resistant Prostate Cancer, Metastatic Malignant Tumor in the Bone, Recurrent Prostate Carcinoma Trial in Buffalo,
Completed
- Hormone-Resistant Prostate Cancer
- +3 more
- Laboratory Biomarker Analysis
- Radiation Therapy
-
Buffalo, New York
- +1 more
Aug 4, 2021
Hormone-Resistant Prostate Cancer, Metastatic Prostate Carcinoma, Recurrent Prostate Carcinoma Trial in Los Angeles, Ann Arbor,
Terminated
- Hormone-Resistant Prostate Cancer
- +3 more
-
Los Angeles, California
- +2 more
Aug 3, 2021
Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer Trial in Detroit (drug, radiation,
Completed
- Adenocarcinoma of the Prostate
- +3 more
- cabozantinib-s-malate
- +4 more
-
Detroit, MichiganBarbara Ann Karmanos Cancer Institute
Aug 3, 2021
Adenocarcinoma of the Prostate, Recurrent Prostate Cancer, Stage I Prostate Cancer Trial in Los Angeles (dietary supplement,
Completed
- Adenocarcinoma of the Prostate
- +6 more
- green tea extract
- +4 more
-
Los Angeles, California
- +1 more
Jun 22, 2021
Castration-Resistant Prostatic Cancer, Metastatic Prostate Carcinoma, Recurrent Prostate Carcinoma Trial in United States (GnRH
Recruiting
- Castration-Resistant Prostatic Cancer
- +4 more
- GnRH agonist/antagonist
- +3 more
-
Los Angeles, California
- +3 more
Apr 30, 2021
Malignant Female Reproductive System Tumor, Malignant Hepatobiliary Tumor, Partner Trial in New Brunswick (Cognitive Behavior
Completed
- Malignant Female Reproductive System Neoplasm
- +38 more
- Cognitive Behavior Therapy
- +3 more
-
New Brunswick, New JerseyRutgers Cancer Institute of New Jersey
Apr 7, 2021
Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer Trial in Detroit (docetaxel,
Completed
- Adenocarcinoma of the Prostate
- +3 more
- docetaxel
- +2 more
-
Detroit, MichiganBarbara Ann Karmanos Cancer Institute
Mar 2, 2021
Stage III Prostate Cancer, Stage IV Prostate Cancer Trial in Duarte (drug, procedure, other)
Completed
- Stage III Prostate Cancer
- Stage IV Prostate Cancer
- axitinib
- +3 more
-
Duarte, CaliforniaCity of Hope Medical Center
Mar 8, 2021
Adenocarcinoma of the Prostate, Recurrent Prostate Cancer, Stage IV Prostate Cancer Trial in Birmingham, Detroit, Columbus
Active, not recruiting
- Adenocarcinoma of the Prostate
- +2 more
- enzalutamide
- +5 more
-
Birmingham, Alabama
- +3 more
Mar 2, 2021
Prostate Cancer Metastatic Castration-Resistant, Abnormal DNA Repair, Metastatic Prostate Carcinoma Trial in United States
Recruiting
- Prostate Cancer Metastatic Castration-Resistant
- +3 more
- Olaparib
- +2 more
-
Duarte, California
- +17 more
Mar 1, 2021
Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer Trial in New Brunswick, Portland
Completed
- Adenocarcinoma of the Prostate
- +3 more
- ipilimumab
- laboratory biomarker analysis
-
New Brunswick, New Jersey
- +1 more
Sep 23, 2020
Drug Resistance in Metastatic Castration-Resistant Prostate
Completed
- Castration Levels of Testosterone
- +5 more
- Cytology Specimen Collection Procedure
- +2 more
-
Los Angeles, California
- +2 more
Sep 24, 2020